You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idebenone

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post Stroke Epilepsy Trial in Changsha (idebenone 30 mg for 14 days, idebenone 30 mg for 3 months)

Recruiting
  • Post Stroke Epilepsy
  • idebenone 30 mg for 14 days
  • idebenone 30 mg for 3 months
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Aug 3, 2023

Naohuan Dan and Idebenone in Treating Mild Cognitive Impairment

Completed
  • Mild Cognitive Impairment
  • Idebenone
  • Naohuan Dan and Idebenone
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital，Sun Yat-sen University，Guangzhou 5
Jun 29, 2023

Migraine Trial in Beijing (Idebenone+ , Idebenone, Placebo)

Recruiting
  • Migraine
  • Idebenone+ placebo
  • +2 more
  • Beijing, China
    Yonggang Wang
Jun 20, 2022

Rapid Eye Movement Sleep Behavior Disorder, Synucleinopathy Trial in Shanghai (Idebenone, Placebo)

Recruiting
  • Rapid Eye Movement Sleep Behavior Disorder
  • Synucleinopathy
  • Idebenone
  • Placebo
  • Shanghai, Shanghai, China
    Department of neurology, Ruijin Hospital, Shanghai Jiao Tong Uni
Apr 26, 2022

Friedreich's Ataxia Trial in Los Angeles, Philadelphia (Idebenone)

Completed
Has Results
  • Friedreich's Ataxia
  • Idebenone
  • Los Angeles, California
  • +1 more
Sep 22, 2021

Migraine Disorders, Headache Disorders Trial in Hangzhou (Placebo, 90mg Idebenone, 270mg Idebenone)

Recruiting
  • Migraine Disorders
  • Headache Disorders
  • Placebo
  • +2 more
  • Hangzhou, Zhejiang, China
    Kaiming Liu
Jun 12, 2021

Non Alcoholic Steatohepatitis Trial in Redwood City, Stanford (Idebenone, Placebo)

Recruiting
  • Non Alcoholic Steatohepatitis
  • Idebenone
  • Placebo
  • Redwood City, California
  • +1 more
Jul 16, 2021

Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone)

Completed
Has Results
  • Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Idebenone
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 27, 2021

REM Sleep Behavior Disorder, Parkinson Disease Trial in Hangzhou (Idebenone, Placebo oral tablet)

Recruiting
  • REM Sleep Behavior Disorder
  • Parkinson Disease
  • Idebenone
  • Placebo oral tablet
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Jul 14, 2021

Huntington Disease Trial in Hangzhou (Haloperidol 2Mg Tab, Risperidone 1Mg Tab, Zoloft 50Mg Tablet)

Recruiting
  • Huntington Disease
  • Haloperidol 2Mg Tab
  • +4 more
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital,Zhejiang University School of Medicin
Mar 30, 2021

Duchenne Muscular Dystrophy (DMD) Trial in Worldwide (Idebenone 150 mg film-coated tablets, )

Terminated
  • Duchenne Muscular Dystrophy (DMD)
  • Idebenone 150 mg film-coated tablets
  • placebo
  • Birmingham, Alabama
  • +62 more
Nov 24, 2021

Leber's Hereditary Optic Neuropathy Trial (Idebenone 150 MG Oral Tablet)

Available
  • Leber's Hereditary Optic Neuropathy
  • Idebenone 150 MG Oral Tablet
  • (no location specified)
May 5, 2020

Post Authorisation Safety Study With Raxone in LHON Patients

Completed
  • Leber's Hereditary Optic Neuropathy (LHON)
  • Idebenone
  • Graz, Austria
  • +25 more
Jul 15, 2021

Duchenne Muscular Dystrophy Trial in United States (Idebenone)

Temporarily not available
  • Duchenne Muscular Dystrophy
  • Idebenone
  • Phoenix, Arizona
  • +11 more
Nov 19, 2019

Leber's Hereditary Optic Neuropathy (LHON) Trial in Worldwide (Idebenone)

Completed
  • Leber's Hereditary Optic Neuropathy (LHON)
  • Idebenone
  • Phoenix, Arizona
  • +28 more
Jul 15, 2021

Childhood Nerve and Muscle Disorders

Recruiting
  • Muscular Dystrophies
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Friedreich Ataxia Trial run by the NINDS (Idebenone)

    Completed
    • Friedreich Ataxia
    • Idebenone
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 15, 2019

    Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone, )

    Completed
    Has Results
    • Primary Progressive Multiple Sclerosis
    • Idebenone
    • placebo
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 6, 2019

    Biomarker for Friedreich's Ataxia (BioFridA)

    Enrolling by invitation
    • FXN Gene
    • +2 more
      • Beirut, Lebanon
        American University of Science and Technology
      Aug 2, 2022

      Oxidative Stress is an Important Cause of Parkinson's Disease Trial (Idebenone/)

      Unknown status
      • Oxidative Stress is an Important Cause of Parkinson's Disease
      • Idebenone/placebo
      • (no location specified)
      Oct 30, 2018

      Freidreich's Ataxia Trial in Worldwide (idebenone)

      Completed
      Has Results
      • Freidreich's Ataxia
      • idebenone
      • Innsbruck, Austria
      • +10 more
      Aug 21, 2017

      Drug-Drug Interaction Trial in Gières (Raxone (idebenone 150 mg), Midazolam 2,5 mg)

      Completed
      • Drug-Drug Interaction
      • Raxone (idebenone 150 mg)
      • Midazolam 2,5 mg
      • Gières, France
        Eurofins Optimed
      Oct 4, 2017

      Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Dystrophy, Becker Trial in Bosisio Parini, Costa Masnaga (Assistive

      Completed
      • Muscular Dystrophies
      • +3 more
      • Assistive device (Armon Ayura) test
      • Assistive device (Jaeco Wrex) test
      • Bosisio Parini, LC, Italy
      • +1 more
      Dec 9, 2019

      Friedreich Ataxia Trial (gamma interferon)

      Completed
      • Friedreich Ataxia
      • gamma interferon
      • (no location specified)
      Feb 25, 2020

      MELAS Syndrome Trial in New York (Idebenone, Placebo)

      Completed
      Has Results
      • MELAS Syndrome
      • Idebenone
      • Placebo
      • New York, New York
        Columbia University Medical Center
      Sep 20, 2016